PREDICTIVE ONCOLOGY
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies.
PREDICTIVE ONCOLOGY
Industry:
Health Care Health Diagnostics Medical Oncology Pharmaceutical
Founded:
2002-01-01
Address:
Eagan, Minnesota, United States
Country:
United States
Website Url:
http://www.predictive-oncology.com
Total Employee:
101+
Status:
Active
Total Funding:
83.78 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Hoy Health
Healthcare company focused on a ecosystem approach to consumer health management that improves health outcomes and reduces costs.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Perceiv AI
AI-driven precision medicine, forecasting disease progression
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-01 | zPREDICTA | zPREDICTA acquired by Predictive Oncology | N/A |
| 2020-07-07 | Quantitative Medicine | Quantitative Medicine acquired by Predictive Oncology | 1.8 M USD |
| 2020-06-02 | Soluble Therapeutics | Soluble Therapeutics acquired by Predictive Oncology | N/A |
| 2020-06-02 | BioDtech | BioDtech acquired by Predictive Oncology | N/A |
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Predictive Oncology
Oasis Capital
Oasis Capital investment in Post-IPO Equity - Predictive Oncology
Key Employee Changes
Official Site Inspections
http://www.predictive-oncology.com Semrush global rank: 9.22 M Semrush visits lastest month: 424
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Predictive Oncology"
Home - Predictive Oncology
He oversees Predictive Oncology’s solubility and stability contracts for numerous pharmaceutical/biotech companies. From 1981 to 2016, Dr. DeLucas was a faculty member at the University of Alabama at Birmingham (UAB) where he …See details»
About us - Predictive Oncology
Predictive Oncology’s solutions additionally include tumor models, biologics development, formulation design, a GMP facility, a CLIA laboratory and substantial scientific domain expertise. ... Harris is also Founder of the Harris Foundation, a non-profit organization that serves socially and economically disadvantaged communities, striving to ...See details»
Predictive Oncology - Crunchbase Company Profile & Funding
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble …See details»
Creating more effective cancer treatments using science, …
Aug 28, 2023 Predictive Oncology has the benefit of the world’s largest privately held biobank containing over 150,000 diverse solid tumor samples. Their biobank is one of three …See details»
Predictive Oncology - LinkedIn
With over 150,000 live-cell tumor samples spanning 137 unique tumor types, Predictive Oncology’s biobank is a vital asset for advancing drug discovery and biomarker research.See details»
Using artificial intelligence- powered evidence-based molecular ...
Tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug discovery solutions, further complimented by its wholly …See details»
Predictive Oncology Inc. - AnnualReports.com
Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and …See details»
Predictive Oncology Inc Company Profile - Overview - GlobalData
Predictive Oncology Inc (Predictive Oncology) is a science-driven company that applies artificial intelligence (“AI”) to support the discovery and development of optimal cancer therapies. ... The company collaborates with pharmaceutical, academic organizations, biotech and diagnostic industries to develop new personalized drugs and ...See details»
Press Releases - Predictive Oncology
PITTSBURGH, May 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that positive …See details»
Predictive Oncology Announces Abstract Accepted for …
Today announced that an abstract has been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held May 31-June 4, …See details»
Predictive Oncology to Participate in Upcoming San Francisco ...
PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. …See details»
Predictive Oncology Announces Positive Results from Ovarian …
May 28, 2024 Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical …See details»
Predictive Oncology Launches Website Highlighting AI-Powered …
Oct 19, 2021 Predictive Oncology is leveraging AI to streamline drug discovery and development, improve outcomes in clinical testing and forge a new frontier of cancer …See details»
Predictive Oncology Announces Abstract Accepted for …
PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract …See details»
Predictive Oncology Enters Biomarker Discovery Market After …
Jul 25, 2024 Predictive Oncology’s biomarker discovery initiative stems, in part, from results obtained in the retrospective ovarian cancer study with UPMC Magee-Womens Hospital, …See details»
Predictive Oncology Announces Progress in Ongoing Evaluation of ...
Nov 13, 2024 Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early biomarker and drug discovery and enable …See details»
Predictive Oncology Announces Progress in Ongoing
4 days ago PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced progress in its …See details»
Frequently Asked Questions - Predictive Oncology
FAQs Frequently asked questions about our solutions Our wide range of solutions covers the oncology spectrum—from drug discovery to clinical treatment. Browse frequently asked …See details»
Predictive Analytics for Personalized Cancer Diagnosis: The Future …
2 days ago Ultimately, the goal of predictive oncology is to enable a future of truly personalized cancer screening, detection, and care. One can envision a world in which an individual‘s cancer risk is continuously updated based on a combination of genomic data, biomarker levels, imaging, and lifestyle factors, triggering precisely tailored screening recommendations and diagnostic …See details»
Press Releases - Predictive Oncology
PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract …See details»